AI/big data haven’t solved healthcare’s challenges. Despite advancements, systemic barriers persist, but AI offers potential to improve outcomes and efficiency. The post Is ‘Big Data’ the Cure-all for U.S. Healthcare? appeared first on MedCity News.
Combining AI-driven insights with tailored care pathways, patients gain access to health coaches, psychologists, and treatment plans, while providers benefit from workflow optimization. The post GVX Venture Studio Launches FusionCare.AI: A One-Stop Shop for Obesity Care at the Future and Health Executive Summit at JPM 2025 appeared first on MedCity News.
Prior authorizations continue to challenge healthcare organizations as payer authorization requirements expand and change. Automated prior authorizations can bring new efficiency and consistency to a process that’s ripe for evolution, but how will providers make the leap? Alicia Pickett, Senior Product Manager at Experian Health, shares her perspectives on the issues providers are talking about…
Jessie Mazar squeezed the grab handle in her husband’s pickup and groaned as contractions struck her during the 90-minute drive from her home in rural northeastern California to the closest hospital with a maternity unit. She could have reached Plumas District Hospital, in Quincy, in just seven minutes. But it no longer delivers babies. Local…
It takes a lot of courage to grow old. I’ve come to appreciate this after conversations with hundreds of older adults over the past eight years for nearly 200 “Navigating Aging” columns. Time and again, people have described what it’s like to let go of certainties they once lived with and adjust to new circumstances….
Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P. Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue. The post At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were…
More than a decade ago, Medtronic announced that a pivotal trial testing its renal denervation system had failed. Though it got approved later, reimbursement has been elusive. All that might change this year. The post Is Medtronic On the Cusp of Rewriting the Story of Renal Denervation? appeared first on MedCity News.
Patient flow automation startup Qventus closed a $105 million Series D financing round. The company’s technology is used by more than 115 hospitals and health systems, including Northwestern Medicine, Banner Health and Allina Health. The post Qventus Snags $105M for Its Patient Flow Automation Tech appeared first on MedCity News.
Solera Health’s $40 million Series E round was co-led by Health Care Service Corporation and included participation from Adams Street, Cobalt Ventures, and Horizon Mutual Holdings, Inc. The post Solera Health Raises $40M Series E Round Co-Led by Health Care Service Corporation appeared first on MedCity News.
“I’d like to see Generalized Cost Effectiveness Analysis become the norm for how we assess value.” – Rep. Jake Auchincloss (D-MA 4th District) See the full interview here. To learn more about GCEA, check out the GCEA User Guide published last year.